Skip to main content

myChEMBL on Bare Metal




myChEMBL is distributed as a Virtual Machine (VM), which is good because you can treat it like another file on your filesystem. It can be transmitted, copied, renamed, deleted, etc. The myChEMBL VM behaves like a sandbox, so software installed there can't harm your computer.

But there are sometimes costs associated with using a VM, for example VMs are usually several percent slower than the host they are running on. There are also a number of scenarios where using a VM may not optimal or even possible, for example:
  • You just want to enrich your existing machine with chemistry-related software
  • The only machine you have is itself virtual - VM provisioning software often prevents you from installing a VM within a VM
  • When performance is critical
In these cases you may not want the whole myChEMBL VM, only the software that it ships with.

Fortunately we have a script, that automates the process of creating our customized VM. But not only that - we keep it publicly available along with all other resources, necessary to build myChEMBL! The main entry point is a bash script called 'bootstrap.sh', which when executed it performs following steps:
  • Creates user called 'chembl' and adds it to sudoers list
  • Updates software distribution channels and upgrades OS
  • Installs common software libraries required by our tools
  • Installs python/ipython notebook/postgres DB
  • Sets up python environment using virtualenvwrapper/virtulenv
  • Downloads ChEMBL_18 data dump, and stores it in freshly created database
  • Installs RDKit and builds postgres cartridge
  • Installs and configures a web server and all resources that will be accessible via browser
  • Configures network
  • Adds some branding

How to use it?

Just run:

curl -s https://raw.githubusercontent.com/chembl/mychembl/master/bootstrap.sh | bash 

you can optionally wrap it with 'time' to know how long did it take to execute: 

time(curl -s https://raw.githubusercontent.com/chembl/mychembl/master/bootstrap.sh | bash) 

It takes about 6 hours on our machines, but we have fast internet connection. It could take 2-3 times longer on your connection, depending on bandwidth and your computer speed. The script is extremely verbose so you will easily notice what is being installed at the moment. Tip: you can redirect stdout/stderr to file(s) or even /dev/null to make it silent.

What takes the most time?

Depending on your configuration these are most time consuming operations performed during execution of the script:
  • Creating fingerprints and indexes for chemistry cartridge
  • Downloading ChEMBL_18 dump from EBI's FTP (917 MB)
  • Compiling libraries
Requirements

Currently 'bootstrap.sh' script was tested only on Ubuntu. It should work on every standard Ubuntu release since 12.04 (and probably Linux Mint as well). It's possible that the script will work fine (after some minor tweaks) with Debian since Ubuntu is based on it and they both use the same package manager. In future we are planning to make it work with other systems (CentOS and RedHat).

Furthermore, in order to execute this script you should have root privileges as it uses 'sudo' many times.

Is it safe?

What we are asking you to do is a "curl pipe sh" pattern, which may be of some security concern.
We believe this is fastest, most convenient and elegant way for majority of our users. If you trust:
  • Your internet connection (no man in the middle, would be hard anyway since we are using https here).
  • github.com.
  • us at ChEMBL (we hope so!)
If you are not convinced, you can do:
  1. curl -o bootstrap.sh  https://github.com/chembl/mychembl/blob/master/bootstrap.sh
  2. Carefully analyze contents, making sure there is no malware
  3. chmod +x bootstrap.sh
  4. ./bootstrap.sh
In that case, please note that this process can be recursive since, bootstrap.sh itself contains "curl pipe sh" pattern many times.

Let us know if you have any follow up questions about this post or about myChEMBL.

Comments

Popular posts from this blog

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

New SureChEMBL announcement

(Generated with DALL-E 3 ∙ 30 October 2023 at 1:48 pm) We have some very exciting news to report: the new SureChEMBL is now available! Hooray! What is SureChEMBL, you may ask. Good question! In our portfolio of chemical biology services, alongside our established database of bioactivity data for drug-like molecules ChEMBL , our dictionary of annotated small molecule entities ChEBI , and our compound cross-referencing system UniChem , we also deliver a database of annotated patents! Almost 10 years ago , EMBL-EBI acquired the SureChem system of chemically annotated patents and made this freely accessible in the public domain as SureChEMBL. Since then, our team has continued to maintain and deliver SureChEMBL. However, this has become increasingly challenging due to the complexities of the underlying codebase. We were awarded a Wellcome Trust grant in 2021 to completely overhaul SureChEMBL, with a new UI, backend infrastructure, and new f

Accessing SureChEMBL data in bulk

It is the peak of the summer (at least in this hemisphere) and many of our readers/users will be on holiday, perhaps on an island enjoying the sea. Luckily, for the rest of us there is still the 'sea' of SureChEMBL data that awaits to be enjoyed and explored for hidden 'treasures' (let me know if I pushed this analogy too far). See here and  here for a reminder of SureChEMBL is and what it does.  This wealth of (big) data can be accessed via the SureChEMBL interface , where users can submit quite sophisticated and granular queries by combining: i) Lucene fields against full-text and bibliographic metadata and ii) advanced structure query features against the annotated compound corpus. Examples of such queries will be the topic of a future post. Once the search results are back, users can browse through and export the chemistry from the patent(s) of interest. In addition to this functionality, we've been receiving user requests for  local (behind the

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

New Drug Approvals - Pt. XVII - Telavancin (Vibativ)

The latest new drug approval, on 11th September 2009 was Telavancin - which was approved for the treatment of adults with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria , including Staphylococcus aureus , both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains. Telavancin is also active against Streptococcus pyogenes , Streptococcus agalactiae , Streptococcus anginosus group (includes S. anginosus, S. intermedius and S. constellatus ) and Enterococcus faecalis (vancomycin susceptible isolates only). Telavancin is a semisynthetic derivative of Vancomycin. Vancomycin itself is a natural product drug, isolated originally from soil samples in Borneo, and is produced by controlled fermentation of Amycolatopsis orientalis - a member of the Actinobacteria . Telavancin has a dual mechanism of action, firstly it inhibits bacterial cell wall synthesis by interfering with the polymerization and cross-linking of peptid